LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 43

Search options

  1. Article: Seronegative rheumatoid arthritis: one year in review 2023.

    De Stefano, Ludovico / D'Onofrio, Bernardo / Gandolfo, Saviana / Bozzalla Cassione, Emanuele / Mauro, Daniele / Manzo, Antonio / Ciccia, Francesco / Bugatti, Serena

    Clinical and experimental rheumatology

    2023  Volume 41, Issue 3, Page(s) 554–564

    Abstract: In the past 20 years, earlier diagnosis and more intensive management have considerably improved the prognosis of rheumatoid arthritis (RA), with milder disease course achieved in particular in seropositive patients. In contrast, seronegative RA has ... ...

    Abstract In the past 20 years, earlier diagnosis and more intensive management have considerably improved the prognosis of rheumatoid arthritis (RA), with milder disease course achieved in particular in seropositive patients. In contrast, seronegative RA has remained largely neglected, and continues to be surrounded by uncertainties regarding its correct diagnosis, clinical phenotype, optimal treatment strategies and relevant outcomes.The purpose of this review is to summarise new insights about the pathogenic, clinical and prognostic peculiarities of seronegative RA that emerged during 2022, and that make this disease subset at least partially different from its seropositive counterpart.
    MeSH term(s) Humans ; Rheumatoid Factor ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/drug therapy ; Prognosis ; Disease Progression
    Chemical Substances Rheumatoid Factor (9009-79-4)
    Language English
    Publishing date 2023-03-23
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    DOI 10.55563/clinexprheumatol/go7g26
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis.

    Bartoletti, Alice / Delvino, Paolo / Minetto, Marco / Milanesi, Alessandra / Bozzalla Cassione, Emanuele / Quadrelli, Verdiana Serena / Luinetti, Ombretta / Monti, Sara / Montecucco, Carlomaurizio

    AIDS research and therapy

    2023  Volume 20, Issue 1, Page(s) 50

    Abstract: Background: Human immunodeficiency virus (HIV) has a protean clinical picture, in rare instances manifesting as systemic autoimmune disorders such as vasculitides. HIV-induced autoimmune diseases often do not respond well to systemic immunosuppressive ... ...

    Abstract Background: Human immunodeficiency virus (HIV) has a protean clinical picture, in rare instances manifesting as systemic autoimmune disorders such as vasculitides. HIV-induced autoimmune diseases often do not respond well to systemic immunosuppressive therapy. Opportunistic infections may occur in patients with either acquired immunodeficiency syndrome (AIDS) or heavy immunosuppressive treatment, and can further complicate the clinical presentation.
    Case presentation: A patient presenting with immunoglobulin A (IgA) vasculitis (IgAV) with treatment-refractory purpuric skin rash and suspect intestinal vasculitis was discovered to have AIDS. HIV was the trigger of IgAV, and cytomegalovirus (CMV) colitis mimicked intestinal vasculitis. Antiretroviral treatment improved both CMV colitis and the control of the autoimmune disease.
    Conclusions: An autoimmune disease relapsing despite adequate immunosuppressive treatment and/or the presence of recurrent severe opportunistic infections may be clues to an underlying HIV infection.
    MeSH term(s) Humans ; Autoimmune Diseases/complications ; Colitis/diagnosis ; Colitis/drug therapy ; Colitis/complications ; Cytomegalovirus Infections/complications ; Cytomegalovirus Infections/diagnosis ; Cytomegalovirus Infections/drug therapy ; HIV ; HIV Infections/complications ; HIV Infections/diagnosis ; HIV Infections/drug therapy ; IgA Vasculitis/complications ; Opportunistic Infections/complications ; Vasculitis/diagnosis ; Vasculitis/drug therapy ; Vasculitis/complications
    Language English
    Publishing date 2023-07-19
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 2173450-1
    ISSN 1742-6405 ; 1742-6405
    ISSN (online) 1742-6405
    ISSN 1742-6405
    DOI 10.1186/s12981-023-00545-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis.

    De Stefano, Ludovico / Bugatti, Serena / Mazzucchelli, Iolanda / Rossi, Silvia / Xoxi, Blerina / Bozzalla Cassione, Emanuele / Luvaro, Terenzj / Montecucco, Carlomaurizio / Manzo, Antonio

    Rheumatology (Oxford, England)

    2023  

    Abstract: Objectives: Autoantibody-negative rheumatoid arthritis (RA) differs from autoantibody-positive RA in several clinical aspects, possibly underpinned by pathogenetic differences. At present, the role of adaptive immune responses in autoantibody-negative ... ...

    Abstract Objectives: Autoantibody-negative rheumatoid arthritis (RA) differs from autoantibody-positive RA in several clinical aspects, possibly underpinned by pathogenetic differences. At present, the role of adaptive immune responses in autoantibody-negative RA remains unclear. Here, we investigated the synovial and serum immunophenotype indicative of B-lymphocyte involvement across the spectrum of autoantibody-positive and -negative chronic arthritides.
    Methods: Ultrasound-guided synovial biopsies were retrieved from 131 patients: 43 autoantibody-positive RA, 35 autoantibody-negative RA, 25 polyarticular psoriatic arthritis (PsA), 28 oligoarticular PsA. Samples were analysed for the degree of histological inflammation, B-lymphocyte infiltration and the distribution of different pathotypes (lympho-myeloid, myeloid, pauci-immune). Serum levels of the B-cell chemoattractant CXCL13 were compared among groups.
    Results: Synovitis scores and CD68+ sublining macrophage infiltration were comparable irrespective of clinical diagnosis and disease subtype. In contrast, the degree of B-lymphocyte infiltration and the frequency of lympho-myeloid synovitis in autoantibody-negative RA were lower than those of autoantibody-positive RA (mean [SD] 1.8 [1] vs 2.4 [0.6], p = 0.03 and 38.2% vs 62.9%, p = 0.07, respectively), and similar to polyarticular PsA. Oligoarticular PsA had the lowest B-cell scores. Serum CXCL13 was associated with lympho-myeloid synovitis and followed a similar gradient, with the highest levels in autoantibody-positive RA, intermediate and comparable levels in autoantibody-negative RA and polyarticular PsA, and low levels in oligoarticular PsA.
    Conclusions: The synovial and serum immunophenotype indicative of B-lymphocyte involvement in autoantibody-negative RA differs from autoantibody-positive RA and more closely resembles that observed in polyarticular PsA. The pathobiological stratification of chronic inflammatory arthritides beyond clinical diagnosis may fuel personalised treatment strategies.
    Language English
    Publishing date 2023-07-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kead378
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis.

    De Stefano, Ludovico / Bozzalla Cassione, Emanuele / Bottazzi, Francesca / Marazzi, Elena / Maggiore, Francesco / Morandi, Valentina / Montecucco, Carlomaurizio / Bugatti, Serena

    Internal and emergency medicine

    2023  Volume 18, Issue 6, Page(s) 1733–1740

    Abstract: Pain remains one of the most difficult-to-treat domains in patients with rheumatoid arthritis (RA). In clinical trials, the Janus kinase inhibitors (JAKis) have demonstrated good efficacy in pain relief. Aim of our study was to evaluate the real-life ... ...

    Abstract Pain remains one of the most difficult-to-treat domains in patients with rheumatoid arthritis (RA). In clinical trials, the Janus kinase inhibitors (JAKis) have demonstrated good efficacy in pain relief. Aim of our study was to evaluate the real-life effectiveness of JAKis in improving pain in patients with RA in different states of baseline disease activity. A monocentric prospective cohort of 181 RA patients starting treatment with JAKis was studied. Pain was evaluated on a 0-100 mm visual analogue scale (VAS). Clinically meaningful improvements over 24 weeks were defined as follows: proportion of patients achieving ≥ 30%, ≥ 50%, and ≥ 70% pain relief, and remaining pain ≤ 20 or ≤ 10 mm. Results were analysed after stratification for baseline inflammatory activity; patients with swollen joints and C-reactive protein ≤ 1 at treatment start were considered pauci-inflammatory. Proportion of patients who achieved ≥ 30%, ≥ 50% and ≥ 70% pain improvement at 24 weeks was 61.4%, 49.3% and 32.9%. Furthermore, 40.6% and 28.5% of the patients achieved thresholds of remaining pain equivalent to mild pain or no/limited pain. Pain improvements were more evident in patients naive to previous biologics, although nearly 30% of multiple failures achieved VAS ≤ 20 mm. No significant differences were observed in relation to monotherapy. Pauci-inflammatory patients at treatment start achieved good outcomes, with 40.4% experiencing ≥ 70% pain improvement, and 35.7% VAS ≤ 10 mm. JAKis show efficacy in pain relief in real life. The improvement of painful symptoms also in those patients with limited objective inflammation may open new perspectives on the management of difficult-to-treat RA.
    MeSH term(s) Humans ; Antirheumatic Agents/therapeutic use ; Janus Kinase Inhibitors/adverse effects ; Prospective Studies ; Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/drug therapy ; Pain/drug therapy ; Pain/etiology
    Chemical Substances Antirheumatic Agents ; Janus Kinase Inhibitors
    Language English
    Publishing date 2023-07-27
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-023-03350-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Established rheumatoid arthritis. The pathogenic aspects.

    Bugatti, Serena / Bozzalla Cassione, Emanuele / De Stefano, Ludovico / Manzo, Antonio

    Best practice & research. Clinical rheumatology

    2020  Volume 33, Issue 5, Page(s) 101478

    Abstract: The development of rheumatoid arthritis (RA), at least in its autoantibody-positive subset, evolves through a series of events starting well before the appearance of synovitis. The distinction between 'early' and 'established' RA is, therefore, an ... ...

    Abstract The development of rheumatoid arthritis (RA), at least in its autoantibody-positive subset, evolves through a series of events starting well before the appearance of synovitis. The distinction between 'early' and 'established' RA is, therefore, an evolving concept. In routine practice, however, the management of RA still starts with the occurrence of clinically detectable synovitis. As such, the synovial membrane remains a major target for the exploitation of possible stage-specific drivers of the disease. The recognition of a 'window of opportunity', in which treatment is more likely to succeed, raises the hypothesis that there might be a period in which the biological processes of RA are less mature and potentially reversible. The present review aims to provide a general picture of the modifications occurring in RA synovium, analysing the contribution of both infiltrating immune cells and stromal cells. When available, differences between early and established RA will be discussed.
    MeSH term(s) Arthritis, Rheumatoid/immunology ; Arthritis, Rheumatoid/pathology ; Autoantibodies ; Humans ; Synovial Membrane ; Synovitis
    Chemical Substances Autoantibodies
    Language English
    Publishing date 2020-01-27
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2052323-3
    ISSN 1532-1770 ; 1521-6942
    ISSN (online) 1532-1770
    ISSN 1521-6942
    DOI 10.1016/j.berh.2019.101478
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola

    Bozzalla Cassione, Emanuele / Zanframundo, Giovanni / Biglia, Alessandro / Codullo, Veronica / Montecucco, Carlomaurizio / Cavagna, Lorenzo

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 4, Page(s) e49

    MeSH term(s) COVID-19 ; Humans ; Pandemics ; SARS-CoV-2 ; Telemedicine
    Keywords covid19
    Language English
    Publishing date 2020-06-05
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-218071
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Insights Into the Concept of Rheumatoid Arthritis Flare.

    Bozzalla-Cassione, Emanuele / Grignaschi, Silvia / Xoxi, Blerina / Luvaro, Terenzj / Greco, Maria Immacolata / Mazzucchelli, Iolanda / Bugatti, Serena / Montecucco, Carlomaurizio / Manzo, Antonio

    Frontiers in medicine

    2022  Volume 9, Page(s) 852220

    Abstract: Identification of a pathological change in the course of systemic chronic immune-inflammatory diseases is key to delivering effective treatment strategies. In this context, one of the most compelling issues is the concept of flare. The multifaceted ... ...

    Abstract Identification of a pathological change in the course of systemic chronic immune-inflammatory diseases is key to delivering effective treatment strategies. In this context, one of the most compelling issues is the concept of flare. The multifaceted expression of disease activity in rheumatoid arthritis (RA) makes it challenging to provide an omni-comprehensive definition of flare, encompassing the pathology's different objective and subjective domains. Our incomplete understanding of the pathophysiological mechanisms underlying this process contributes to the partial comprehension of its potential clinical expression. This review focuses on the proposed pathophysiological processes underlying disease recrudescence in RA and the variable definitions adopted to capture flare in clinical practice through its objective, subjective, and temporal domains. Overall, what emerges is a complex landscape far from being unraveled.
    Language English
    Publishing date 2022-03-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2022.852220
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno

    Bozzalla Cassione, Emanuele / Zanframundo, Giovanni / Biglia, Alessandro / Codullo, Veronica / Montecucco, Carlomaurizio / Cavagna, Lorenzo

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 5, Page(s) e66

    MeSH term(s) Arthritis, Rheumatoid/drug therapy ; Arthritis, Rheumatoid/epidemiology ; COVID-19 ; Humans ; Pandemics ; SARS-CoV-2 ; Telemedicine
    Keywords covid19
    Language English
    Publishing date 2020-06-25
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-218193
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina

    Bozzalla Cassione, Emanuele / Zanframundo, Giovanni / Biglia, Alessandro / Codullo, Veronica / Montecucco, Carlomaurizio / Cavagna, Lorenzo

    Annals of the rheumatic diseases

    2020  Volume 80, Issue 4, Page(s) e51

    MeSH term(s) COVID-19 ; Humans ; Hydroxychloroquine ; Lupus Erythematosus, Systemic ; Pandemics ; Rheumatic Diseases/therapy ; Telemedicine
    Chemical Substances Hydroxychloroquine (4QWG6N8QKH)
    Keywords covid19
    Language English
    Publishing date 2020-06-05
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-218070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis.

    Delvino, Paolo / Bozzalla-Cassione, Emanuele / Biglia, Alessandro / Quadrelli, Verdiana Serena / Bartoletti, Alice / Montecucco, Carlomaurizio / Monti, Sara

    Clinical and experimental rheumatology

    2021  Volume 40, Issue 4, Page(s) 853

    MeSH term(s) Aged ; BNT162 Vaccine ; COVID-19/prevention & control ; Humans ; Immunocompromised Host ; RNA, Messenger ; Systemic Vasculitis
    Chemical Substances RNA, Messenger ; BNT162 Vaccine (N38TVC63NU)
    Language English
    Publishing date 2021-09-16
    Publishing country Italy
    Document type Letter
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    DOI 10.55563/clinexprheumatol/xj2pqk
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top